1. Home
  2. SEPN vs TTGT Comparison

SEPN vs TTGT Comparison

Compare SEPN & TTGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • TTGT
  • Stock Information
  • Founded
  • SEPN 2022
  • TTGT 1999
  • Country
  • SEPN United States
  • TTGT United States
  • Employees
  • SEPN N/A
  • TTGT N/A
  • Industry
  • SEPN
  • TTGT Telecommunications Equipment
  • Sector
  • SEPN
  • TTGT Telecommunications
  • Exchange
  • SEPN NYSE
  • TTGT Nasdaq
  • Market Cap
  • SEPN 1.0B
  • TTGT 810.0M
  • IPO Year
  • SEPN 2024
  • TTGT 2007
  • Fundamental
  • Price
  • SEPN $22.40
  • TTGT $20.09
  • Analyst Decision
  • SEPN Strong Buy
  • TTGT Strong Buy
  • Analyst Count
  • SEPN 4
  • TTGT 6
  • Target Price
  • SEPN $43.67
  • TTGT $38.17
  • AVG Volume (30 Days)
  • SEPN 237.6K
  • TTGT 324.7K
  • Earning Date
  • SEPN 02-15-2025
  • TTGT 02-05-2025
  • Dividend Yield
  • SEPN N/A
  • TTGT N/A
  • EPS Growth
  • SEPN N/A
  • TTGT N/A
  • EPS
  • SEPN N/A
  • TTGT N/A
  • Revenue
  • SEPN $981,000.00
  • TTGT $260,750,999.00
  • Revenue This Year
  • SEPN N/A
  • TTGT $1.57
  • Revenue Next Year
  • SEPN N/A
  • TTGT $6.46
  • P/E Ratio
  • SEPN N/A
  • TTGT N/A
  • Revenue Growth
  • SEPN N/A
  • TTGT N/A
  • 52 Week Low
  • SEPN $18.62
  • TTGT $19.57
  • 52 Week High
  • SEPN $27.47
  • TTGT $41.93
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • TTGT 27.91
  • Support Level
  • SEPN N/A
  • TTGT $19.57
  • Resistance Level
  • SEPN N/A
  • TTGT $28.44
  • Average True Range (ATR)
  • SEPN 0.00
  • TTGT 2.35
  • MACD
  • SEPN 0.00
  • TTGT -0.82
  • Stochastic Oscillator
  • SEPN 0.00
  • TTGT 3.85

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About TTGT TechTarget Inc.

TechTarget Inc is a data, software and analytics leader for purchase intent-driven marketing and sales data which delivers business impact for business-to-business (B2B) companies. The company solutions are designed to enable B2B technology companies to identify, reach, and influence key enterprise technology decision makers faster and with higher efficacy. Geographically, it derives a majority of its revenue from North America. Its products and services intended to improve information technology vendors abilities to impact targeted audiences for business growth using targeting, first-party analytics and data services complemented with customized marketing programs that integrate content creation, demand generation, brand marketing, and other advertising techniques.

Share on Social Networks: